ihe publications 2011-2015 · terapi kan ge ökad effektivitet läkartidningen, 2014 jun 11-17; 111...

www.ihe.se

PUBLICATIONS 2015-2011

1 Med reservation för ofullständiga referenser

PUBLICATIONS 2015

Journath G, Hammar N, Elofsson S, Linnersjo A, Vikstrom M, Walldius G, Lindgren P et al.

Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a

Cardiovascular Prevention Program in Sweden.

PloS one. 2015; 10(11):e0140201

Landfeldt E, Mayhew A, Eagle M, Lindgren P, Bell CF, Guglieri M, et al.

Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-

Assessment Tool (DMDSAT).

Neuromuscul Disord. 2015; 25(12): 937-44

Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al.

Compliance to Care Guidelines for Duchenne Muscular Dystrophy.

Journal of Neuromuscular Diseases. 2015; 2(1): 63-72

Gralén K, Andersson E, Ahlberg I, Steen Carlsson K & Olofsson S

Hemtjänst, vård- och omsorgsboende eller mitt emellan? Ett kunskapsunderlag för planeringen av

morgondagens äldreomsorg

Stockholm: Myndigheten för vård- och omsorgsanalys, 2015.

Rapport 2015:8

Olofsson S, Gralén K, Ahlberg I & Persson U

Värdet av färre administrationstillfällen för personer med multipel skleros (MS) som behandlas med

injektionsläkemedel. En betalningsviljestudie

Lund: IHE Rapport 2015:2

Kjellsson G, Gerdtham UG & Petrie D

Lies, Damned Lies, and Health Inequality Measurements: Understanding the Value Judgments.

Epidemiology. 2015 Sep; 26(5): 673-680

Hansen F, Anell A, Gerdtham UG & Lyttkens CH

The Future of Health Economics: The Potential of Behavioral and Experimental Economics

Nordic Journal of Health Economics, 2015.

Gerdtham UG, Lundborg P, Lyttkens CH & Nystedt P

Do Education and Income Really Explain Inequalities in Health? Applying a Twin Design

Scandinavian Journal of Economics.

Berg J, Lindgren P, Mejhert M, Edner M, Dahlström U & Kahan T

Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart

Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry

Value Health. 2015 Jun; 18(4): 439-48.

www.ihe.se



Ragnarson Tennvall G., Norlin J.M., Malmberg I., Erlendsson A.M. & Hædersdal M.

Health related quality of life in patients with actinic keratosis – an observational study of patients treated in

dermatology specialist care in Denmark

Health and Quality of Life Outcomes 2015; 13(111): 1-9

Persson U & Jönsson B

The End of the International Reference Pricing System?

Appl Health Econ Health Policy. Publicerad online: 26 juni 2015

Ragnarson Tennvall G & Lundqvist A

Screening för livmoderhalscancer. Rekommendation och bedömningsunderlag. Bilaga: Värdet av

populationsbaserad screening för livmoderhalscancer. Hälsoekonomisk analys av HPV-test och cytologi

Stockholm: Socialstyrelsen, 2015. Artikelnummer: 2015-6-39

Öien RF, Forsell H & Ragnarson Tennvall G

Cost consequences due to reduced ulcer healing times – analyses based on the Swedish Registry of Ulcer

Treatment

Int Wound J. 2015

Pickwell K, Siersma V, Kars M, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jirkovská A, Jude E, Mauricio D,

Piaggesi A, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J & Schaper

N

Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer

Diabetes Care. 2015; 38: 852-857

Steen Carlsson K, Andersson E, Lundqvist A & Willis M

PÅVERKBARA KOSTNADER FÖR TYP 2-DIABETES ÅR 2020 OCH ÅR 2030 I SVERIGE. Prognoser med IHE Cohort

Model of Type 2 Diabetes

Lund: IHE Rapport 2015:1

Neslusan C, Teschemaker A, Johansen P, Willis M, Valencia-Mendoza A & Puig A

Cost-Effectiveness of Canagliflozin versus Sitagliptin as Add-on to Metforminin Patients with Type2 Diabetes

Mellitus in Mexico

Value in health regional issues 2015; 8C: 8-19

Jönsen A, Bengtsson AA, Hjalte F, Petersson IF, Willim M & Nived O

Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception

cohort

Lupus. 2015 Oct;24(12):1248-56

Hofmarcher T & Borg S

Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in

Sweden

Journal of Medical Economics. 2015; 18(7): 492-501

www.ihe.se



Baghaipour MR & Steen Carlsson K

Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical

studies

Eur J Haematol. 2015 Feb; 94 Suppl 77: 30-7

Hjalte F, Steen Carlsson K & Schmitt-Egenolf M

Real-World Outcome Analysis of Continuously and Intermittently Treated Patients with Moderate to Severe

Psoriasis after Switching to a Biologic Agent

Dermatology 2015. Publicerad online 20 februari 2015

Steen Carlsson K, Hjalte F, Lundqvist A, Ragnarson Tennvall G, Häger Glenngård A, Nilsson S & Lundgren C

medverkan i

Nationella riktlinjer Diabetesvård 2015. Stöd för styrning och ledning

Stockholm: Socialstyrelsen, 2015.

Artikelnummer: 2015-2-3

Norlin J, Steen Carlsson K, Persson U & Schmitt-Egenolf M

Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden

Acta Derm Venereol 2015; 95: 156–161

Norrlid H, Dahm P & Ragnarson Tennvall G

Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D

weights

Scandinavian Journal of Pain 2015; 6: 24-30

PUBLICATIONS 2014

Kiadaliri AA, Gerdtham UG, Eliasson B & Carlsson KS Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in sweden. Diabetes Ther. 2014 Dec; 5(2): 591-607 Epub 2014 Sep 12 Olofsson S & Hjalte F Samhällets kostnader för utbrottet av pandemisk influensa A(H1N1) 2009/2010 MSB - Myndigheten för samhällsskydd och beredskap Publikationsnummer MSB795-December 2014 Borg S, Palaszewski B, Gerdtham U-G, Ödegaard F, Roos P and Gudbjörnsdottir S Patient-Reported Outcome Measures and Risk Factors in a Quality Registry: A Basis for More Patient-Centered Diabetes Care in Sweden International Journal of Environmental Research and Public Health 2014, 11, 12223-12246 Lundqvist A, Steen Carlsson K, Johansen P, Andersson E & Willis M Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations PLOS ONE 2014; 9(10): 1-12

www.ihe.se



Lökk J, Olofsson S & Persson U Willingness to pay for a new drug delivery in Parkinson patients Journal of Multidisciplinary Healthcare 2014; 7: 431–440 Ida Ahlberg KOSTNADER FÖR RÖRELSEORGANENS SJUKDOMAR I SVERIGE ÅR 2012 Lund: IHE Rapport 2014:4 Romé Å, Persson U, Ekdahl C & Gard G Costs and outcomes of an exercise referral program - a 1-year follow-up study European Journal of Physiotherapy 2014; Early Online: 1-11 Vataire A-L, Aballéa S, Antonanzas F, Hakkaart- van Roijen L. Lam R, McCrone P, Persson U & Toumi M Core Discrete Event Simulation Model for the Evaluation of Health care Technologies in Major Depressive Disorder Value in Health 01/2014, 17(2): 183-195 Saulyte Trakymiene S & Steen Carlsson K On-demand treatment in persons with severe haemophilia Eur J Haematol Suppl. 2014 Aug;76:39-47 Ohm L, Lundqvist A, Dickman P, Höglund M, Persson U, Stenke L, Steen Carlsson K & Björkholm M Real-world cost-effectiveness in chronic myeloid leukaemia: The price of success during four decades of development from non-targeted treatment to imatinib Leuk Lymphoma, 2014 Aug 20:1-16. Borg S, Näslund I, Persson U & Ödegaard K Obesity and Surgical Treatment - A Cost-Effectiveness Assessment for Sweden Nordic Journal of Health Economics 2014

Löfvendahl S, Theander E, Svensson Å, Steen Carlsson K, Englund M & Petersson IF Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden - a population-based register study PLOS ONE 2014; 9(5): 1-10 Hoogendoorn M, Feenstra TL, Asukai Y, Borg S, Hansen RN, Jansson S-A, Samyshkin Y, Wacker W, Briggs AH, Lloyd A, Sullivan SD & Rutten-van Mölken MPMH Cost-effectiveness models for chronic obstructive pulmonary disease (COPD): cross-model comparison of hypothetical treatment scenarios Value Health, 2014 Jul; 17(5): 525-36 Norlin JM, Schmitt-Egenolf M, Steen Carlsson K, & Persson U Registerstudier mäter effektivitet av läkemedel I klinisk praxis. Exemplet PsoReg – omfördelning av systemisk terapi kan ge ökad effektivitet Läkartidningen, 2014 Jun 11-17; 111(24): 1061-3 Steen Karlsson K & Persson U Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin Journal of Medical Economics. Posted online on June 26, 2014

www.ihe.se



Edited by Anthony J Culyer and Gisela Kobelt PORTRAIT OF A HEALTH ECONOMIST, ESSAYS BY COLLEAGUES AND FRIENDS OF BENGT JÖNSSON IHE, Lund, Sweden 2014 Persson U Cost-Benefit Analysis and the use of individual’s willingness-to-pay for health improvements in the health care In PORTRAIT OF A HEALTH ECONOMIST, ESSAYS BY COLLEAGUES AND FRIENDS OF BENGT JÖNSSON Edited by Anthony J Culyer and Gisela Kobelt. IHE, Lund, Sweden 2014. Ragnarson Tennvall G, Hjalte F & Lundqvist A medverkan i Nationella riktlinjer 2014. Bröst-, prostata-, tjocktarms- och ändtarmscancervård – Stöd för styrning och ledning Stockholm: Socialstyrelsen, 2014. Artikelnummer: 2014-4-2 Norlin JM, Steen Carlsson K, Persson U & Schmitt-Egenolf M Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden Acta Derm Venereol. Kiadaliri AAK, Gerdtham U-G, Nilsson P, Eliasson B, Gudbjörnsdottir S & Steen Carlsson K Health Utilities of Type 2 Diabetes-Related Complications: a Cross-Sectional Study in Sweden Int J Environ Res Public Health, 2014 May 7; 11(5): 4939-52 Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovská A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J & Schaper NC. Health-Related Quality of Life predicts major amputation and death, but not time to healing, in people with diabetes mellitus presenting with foot ulcers: the Eurodiale study Diabetes Care 2014; 37(3): 694-700

Willis M, Erntoft S, Persson S, Norlin J, Persson U Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting Journal of Health Economics and Outcomes Research 2014; 2(1): 1-14 Hofmarcher T, Jönsson B & Wilking N Access to high-quality oncology care across Europe Lund: IHE Report 2014:2 Kjellsson G & Gerdtham U-G Measuring health inequalities using the concentration index approach. Kapitel i Encyclopedia of Health Economics, 1st Edition. Encyclopedia of Health Economics, Vol 2. Editor in Chief: A J Culyer San Diego: Elsevier April 2014 pp 240-246 Burström K, Sun S, Gerdtham U-G, Henriksson M, Johannesson M, Levin L-Å & Zethraeus N Swedish experience-based value sets for EQ-5D health states Quality of Life Research, 2014; 23: 431-442 Olofsson S & Persson U Värdet av ett nytt sätt att administrera levodopa Lund: IHE Rapport 2014:1

http://www.ihe.se/resource-use-in.aspx

www.ihe.se



Garmy P, Jakobsson U, Steen Carlsson K, Berg A & Clausson EK Evaluation of a School-Based Program Aimed at Preventing Depressive Symptoms in Adolescents Journal of School NursinG. Online Feb 2014

PUBLICATIONS 2013

Jönsson B & Steen Carlsson K Värdet av läkemedel Stockholm: SNS Förlag November 2013 Gerdtham U G & Lyttkens C H Vad kostar ojämlikhet i hälsa? (Och varför vill vi veta det?) Läkartidningen 2013; 110(47): 2124 (Debatt) Ljungvall Å, Gerdtham U G & Lindblad U Misreporting and misclassification: implications for socioeconomic disparities in body-mass index and obesity The European Journal of Health Economics .This article is published with open access at Springerlink.com December 2013 Nordin M & Gerdtham U G Why a positive link between age and income-related health inequality? Nordic Journal of Health Economics November 2013 Saha S & Gerdtham U G Cost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature review Health Economics Review 2013, 3:24 Dahlrup B, Nordell A, Steen Carlsson K & S Elmståhl S Health Economic Analysis on a Psychosocial Intervention for Family Caregivers of Persons with Dementia Dement Geriatr Cogn Disord 2013; 37: 181–195 Saha S, Steen Carlsson K, Gerdtham U G, Eriksson M K, Hagberg L, Eliasson & Johansson P Are Lifestyle Interventions in Primary Care Cost-Effective? – An Analysis Based on a Markov Model, Differences-In-Differences Approach and the Swedish Björknäs Study PLoS ONE 8(11): e80672, 2013 Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovská A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J & Schaper NC. Health-Related Quality of Life predicts major amputation and death, but not time to healing in people with diabetes mellitus presenting with foot ulcers - the Eurodiale study. Diabetes Care. 2013 Oct 29. [Epub ahead of print] Andersson B, Appelgren B, Sjödin V, Ansari D, Nilsson J, Persson U, Tingstedt B & Andersson R Acute pancreatitis - costs for healthcare and loss of production Scandinavian journal of gastroenterology (Impact Factor: 2.08). 10/2013 Posted online on October 16, 2013

www.ihe.se



Glenngård AH Objectives, actors and accountability in quasi-markets: Studies of Swedish primary care Doktorsavhandling 2013. Lund: Lunds universitet, Ekonomihögskolan. Lilje S, Persson U, Tessem Tangen S, Kåsamoen S & Skillgate E Costs and utilities of manual therapy and orthopedic standard care for low prioritized orthopedic outpatients of working age: A cost consequence analysis Clinical Journal of Pain (Forthcoming) Hjalte F & Olofsson S SAMHÄLLETS KOSTNADER FÖR ATT FÖREBYGGA DRUNKNINGSOLYCKOR Delprojekt i kostnaderna av samhällets säkerhetsarbete Lund: IHE Rapport 2013:1 Burström K, Sun S, Gerdtham U-G, Henriksson M, Johannesson M, Levin L-Å & Zethraeus N Swedish experience-based value sets for EQ-5D health states Quality of Life Research, Published online 22 August 2013. Fischer K, Steen Carlsson K, Petrini P, Holmström M, Ljung R, van der Berg H M and Berntorp E Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s Blood, 2013; 122(7): 1129-1136 Anell A & Glenngård AH Vad gör primärvården för äldre med komplexa behov? Arbetssätt och samverkan vid åtta mottagningar i Region Skåne samt implikationer för landsting och kommuner Stockholm: Leading Health Care, 2013. Willis M, Asseburg C & He J Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM) Journal of Medical Economics 2013; 16(8): 1007-1021 Ghatnekar O, Andersson R, Svensson M, Persson U, Ringdahl U, Zeilon P and Borrebaeck Carl AK Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature International Journal of Cancer, Online 6 May 2013 Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J and Schaper NC Importance of factors determining the low health-related quality of life in people presenting with a diabetic foot ulcer: the Eurodiale study Diabetic Medicine 2013 Glenngård AH Productivity and patient satisfaction in primary care – Conflicting or compatible goals? Health Policy 2013 Kjellsson G and Gerdtham U-G Lost in translation: rethinking the intermediate value judgment for health inequalities Research on Economic Inequality. 2013. In Press

http://www.ihe.se/vad-gor-primarvarden.aspx

http://www.ihe.se/vad-gor-primarvarden.aspx

www.ihe.se



Kiadaliri AA, Jafari M and Gerdtham U-G Frontier-based techniques in measuring the hospitalists’efficiency in Iran: a systematic review and meta analysis BMC Health Services Research 2013. Jarl J, Heckley G, Brummer J & Gerdtham U-G Time characteristics of the effect of alcohol cessation on the risk of stomach cancer: a meta-analysis BMC Public Health 2013; 13: 600 Saha S, Leijon M, Gerdtham U-G, Groop L, Sundquist K, Sundquist J, Winkleby M, Arvidsson D and Bennet LA culturally adopted lifestyle intervention for Middle Eastern Immigrant population at risk for diabetes: The intervention phase study protocol of MEDIM (The impact of Migration and Ethnicity on Diabetes In Malmö) Trials. 2013. Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkilä H, Jemec GB, Kragballe K, Miller IM & Svensson A. Treatment Patterns, Treatment Satisfaction, Severity of Disease Problems, and Quality of Life in Patients with Psoriasis in Three Nordic Countries Acta Derm Venereol 2013; 93: 442-445 Kiadaliri AA, Hosseinpour R, Haghparast-Bidgoli H & Gerdtham, U-G Pure and Social Disparities in Distribution of Dentists: A Cross-Sectional Province-Based Study in Iran International Journal of Environmental Research and Public Health. 2013; 10: 1882-1894 Axelson H, Gerdtham U-G, Ekman B, Dinh Thi Phuong Hoa and Alfvén T Inequalities in reproductive, maternal, newborn and child health in Vietnam: a retrospective study of survey data for 1997-2006 BMC Health Services Research 2013; 12: 456 Kjellsson G and Gerdtham U-G On correcting the concentration index for binary variables Journal of Health Economics 2013; 32: 659-670 Kiadaliri A.A, Jarl J, Gavriilidis G and Gerdtham U-G Alcohol drinking cessation and the risk of laryngeal and pharyngeal cancers: a systematic review and meta-analysis PLoS ONE 2013: 8(3): e58158 Kiadaliri AAK, Gerdtham U-G, Nilsson P, Eliasson B, Gudbjörnsdottir S, Steen Carlsson K Towards renewed health economic simulation of type 2 diabetes: Risk equations for first and second cardiovascular events from Swedish register data PloSOne 2013; 8(5): e62650 Kiadaliri AAK, Clarke PM, Gerdtham U-G, Nilsson P, Eliasson B, Gudbjörnsdottir S, Steen Carlsson K Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register Journal of Diabetes Research. 2013. Article ID 241347 Rosberg HE, Steen Carlsson K, Cederlund IR, Ramel E, Dahlin LB Costs and outcome for serious hand and arm injuries during the first year after trauma -- a prospective study BMC Public Health 2013; 13: 501.

www.ihe.se



Svensson J, Borg S & Nilsson P Costs and quality of life in multiple sclerosis patients with spasticity Acta Neurol Scand. 2013 May 18 Persson S, Dahlquist G, Gerdtham UG & Steen Carlsson K Impact of childhood-onset type 1 diabetes on schooling: a population-based register study Diabetologia, 2013; 56(6): 1254-1262 Lundqvist A, Wilking N, Gerdtham U-G, Persson U & Steen Carlsson K Johanna Lind (red.) Målriktad behandling av bröstcancer Fem rapporter om värdet av nya läkemedel. Stockholm: SNS, februari 2013. Steen Carlsson K, Berne C, Johansen P, Lanne G & Gerdtham U-G Johanna Lind (red.) Behandling av diabetes i ett hundraårigt perspektiv Fem rapporter om värdet av nya läkemedel. Stockholm: SNS, februari 2013. Lundqvist A, Norlenius Ohm A-C, Dickman P, Höglund M, Stenke L, Gerdtham U-G, Persson U, Björkholm M & Steen Carlsson K Johanna Lind (red.) Medicinska framsteg i behandling av kronisk myeloisk leukemi Fem rapporter om värdet av nya läkemedel. Stockholm: SNS, februari 2013. Norlin J M, Steen Carlsson K, Persson U & Schmitt-Egenolf M Switch to Biological Agent in Psoriasis Significantly Improved Clinical and Patient-Reported Outcomes in Real-World Practice Dermatology Published Online First: January 16, 2013 Ghatnekar O, Bondesson O, Persson U & Eriksson T Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital BMJ Open 2013;3:e001563 Pickwell KM, Siersma VD, Kars M, Holstein PE, Schaper NC; Eurodiale consortium. Collaborators: Prompers L, Huiberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jude E, Jirkovská A, Mauricio D, Piaggesi A, Reike H, Spraul M, van Acker K, van Baal S, van Merode F, Uccioli L, Urbancic V, Ragnarson Tennvall G. Diabetic foot disease: impact of ulcer location on ulcer healing Diabetes Metab Res Rev. 2013; 29(5): 377-383

PUBLICATIONS 2012

Glenngård A & Anell A

Produktivitet och patientnöjdhet i primärvården - en studie av Region Halland, Region Skåne och Västra

Götalandsregionen

Lund: KEFU, 2012 (Rapport 2012:2)

www.ihe.se



Glenngård AH, Hjelmgren J, Thomsen PH & Tvedten T

Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice

experiment (DCE) in Sweden, Denmark and Norway

Nord J Psychiatry. 2012 Dec 17.

Anell A, Glenngård AH & Merkur S

Sweden health system review

Health Syst Transit. 2012; 14(5): 1-159

Anell A, Nylinder P & Glenngård A

Vårdval i primärvården: jämförelse av uppdrag, ersättningsprinciper och kostnadsansvar

Stockholm: Sveriges Kommuner och Landsting, 2012

Glenngård A H

Is patient satisfaction in primary care dependent on structural and organizational characteristics among

providers? Findings based on data from the national patient survey in Sweden

Health Economics, Policy and Law. 2012, FirstView Article, pp 1-16

Asseburg C, Willis M, Löthgren M, Seppälä N, Hakala M & Persson U

Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of

Risperidone Long-Acting Injection

Schizophrenia Research and Treatment. 2012; Volume 2012, Article ID 791468, 9 pages

Anderberg S & Svensson M

Vård och omsorg i hemmet för personer med multipel skleros

IHE Rapport 2012:6

Svensson J, Lundberg J, Olsson P, Stjärne P & Tennvall GR

Cost-effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis

Prim Care Respir J. 2012; 21(4): 412-8

Borg S, Näslund I, Persson U & Ödegaard K

Budget impact analysis of surgical treatment for obesity in Sweden

Scandinavian Journal of Surgery 2012; 101(3): 190–197

Lökk J, Persson U & Wainwright M

Social and Economic Benefits of Early Optimised Treatment for Parkinson´s Disease Patients - Improved

Quality of Life and Greater Productivity

European Neurological Review 2012; 7(2): 113-117

Hjalte F, Brännström J & Gerdtham U G

Societal costs of hearing disorders: A systematic and critical review of literature

International Journal of Audiology, 2012; 51(9): 655-662

www.ihe.se



Lindvall K, Astermark J, Björkman S, Ljung R, Steen Carlsson K, Persson S and Berntorp E

Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and

efficacy

Haemophilia, 2012, publicerad online den 11 juni

Persson U, Svensson J & Pettersson B.

A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market

Pricing.

Applied Health Economics and Health Policy, 2012; 10(4): 217-25

Svensson J, Ghatnekar O, Lindgren A, Lindvall O, Norrving B, Persson U & Kokaia Z

Societal Value of Stem Cell Therapy in Stroke - A Modeling Study.

Cerebrovascular Diseases, 2012; 33(6): 532-539

Thorsén F, Rosberg H-E, Steen Carlsson K & Dahlin L B.

Digital nerve injuries: Epidemiology, results, costs, and impact on daily life

Journal of Plastic Surgery and Hand Surgery, 2012; 46(3-4): 184-90

Ghatnekar O. & Steen Carlsson K.

Kostnader för insjuknande i stroke år 2009. En incidensbaserad studie.

Lund: IHE, 2012 (IHE Rapport 2012:2)

Steen Carlsson K. & Persson U.

Kostnader för hjärt-kärlsjukdom år 2010


Ghatnekar O, Ljungberg A, Wirestrand LE, Svensson A.

Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden - a cross-

sectional study.

European Journal of Dermatology. 2012 Mar-Apr;22(2):238-45.

Glenngård H Anna & Anell A.

Vad påverkar patientupplevd kvalitet i primärvården?

Stockholm : Myndigheten för vårdanalys, 2012 (Rapport 2012:1)

Lundqvist A, Levin L-Å, Persson U & Steen Carlsson K

Värdet av forskning och ny medicinsk teknologi för hjärt–kärlsjukdom – en studie utifrån exemplet ischemisk

hjärtsjukdom


Lökk J, Borg S, Svensson J,Persson U & Ljunggren G

Drug and treatment costs in Parkinson´s disease patients in Sweden

Acta Neurologica Scandinavica 2012 Feb;125(2):142-7

www.ihe.se



Norlin J M, Steen Carlsson K, Persson U & Schmitt-Egenolf M

Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients

British Journal of Dermatology. 2012; 166(4): 797-802

Svensson, M.

Prioritering av innovativa läkemedel – erfarenheter inom ögonsjukvården i Danmark, Norge och Sverige.


Anderberg EA, Steen Carlsson K, Berntorp K

Use of health care resources after gestational diabetes mellitus – A longitudinal case-control analysis

Scandinavian Journal of Public Health. 2012 Jun; 40(4): 385-90

Tiberg I, Steen Carlsson K, Carlsson A, Hallström I

Children diagnosed with type 1 diabetes: a randomized controlled trial comparing hospital versus home-

based care

Acta Paediatr. 2012 Oct; 101(10): 1069-73

Tiberg I, Steen Carlsson K, Carlsson A, Hallström I

Metabolic control, health care satisfaction and costs one month after diagnosis of type 1 diabetes: A

randomised controlled trial of hospital-based care versus hospital-based home care

Pediatric diabetes. 2012 Jul 2

PUBLICATIONS 2011

van Battum P, Schaper N, Prompers L, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P,

Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal

J, Ferreira I & Huijberts M

Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by

differences in disease severity at presentation

Diabet Med. 2011 Feb; 28(2): 199-205

Svensson M.

Uppföljning Fritt val av hjälpmedel. En enkätstudie till hjälpmedelsanvändare som via Fritt val köpt

hjälpmedel under perioden maj 2008 - december 2009. Slutrapport. - Bilaga 6 I: Tilläggsuppdrag angående

försöksverksamheten Fritt val av hjälpmedel 2009-2011.

Stockholm : Hjälpmedelsinstitutet, 2011

Persson U & Svensson M

Särläkemedel - en utmaning för det värdebaserade prissättningssystemet för läkemedel

IHE Rapport 2011:3

www.ihe.se



Svensson M

Kostnader för nuvarande och utvidgad hälso- och sjukvård för asylsökande och papperslösa, Bilaga 2

Vård efter behov och på lika villkor –en mänsklig rättighet. Betänkande av Utredningen om vård för

papperlösa m.fl.

Stockholm SOU 2011:48.

Glenngård AH, Anell A & Beckman A

Choice of primary care provider: Results from a population survey in three Swedish counties

Health Policy 2011; 103(1): 31-37

Glenngård AH & Ödegaard K

Kostnadsanalys för hepatit B-vaccination

Stockholm: Socialstyrelsen, 2011.

Artikelnummer: 2010-1-22

Studien kan laddas ner som pdf eller beställas hos Socialstyrelsen

Olofsson S, Wickström A, Glenngård A H, Persson U & Svenningsson A

Effect of treatment with Natalizumab on ability to work in people with Multiple Sclerosis – productivity gain

based on a direct measurement of work capacity before and after 1 year of treatment

BioDrugs 2011; 25 (5): 299-306

Persson U & Ödegaard K

Fetma ett ekonomiskt samhällsproblem -kostnader och möjliga åtgärder i Sverige

Ekonomisk Debatt 2011; 39: 39-49

Gerdtham Ulf-G, Persson U & Steen Carlsson K

Värdet av nya läkemedel - en förstudie

Stockholm: SNS Förlag, 2011.

Hjortsberg C, Helldin L, Hjärthag F & Löhtgren M

Costs for Patients with Psychotic Illness - Differences Depending on State of Remission

J Ment Health Policy Econ 2011; 14(2): 87-93

Hjortsberg C, Bergman A, Bjarnsson A, Heikkilä H, Hjelmgren J, Svensson Å & Tennvall Ragnarson G

Are Treatment Satisfaction, Quality of Life, and Self-assessed Disease Severity Relevant Parameters for

Patient Registries? Experiences from Finnish and Swedish Patients with Psoriasis

Acta Derm Venereol 2011; 91: 409–414

Nuijten MJ, Mittendorf T and Persson U

Practical issues in handling data input and uncertainty in a budget impact analysis

Eur J Health Econ. 2011; 12(3): 231-241

Jarl J & Gerdtham Ulf-G

Ekonomiska utvärderingar av organtransplantationer - en systematisk litteraturöversikt

IHE RAPPORT 2011:2

http://www.socialstyrelsen.se/

www.ihe.se



Glenngård Häger A, Carlsson Steen K & Berglund A

Ekonomiska konsekvenser av våld mot kvinnor - En kunskapsöversikt samt kostnadsberäkningar utifrån tre

typfall

IHE RAPPORT 2011:1

Glenngård Häger A, Carlsson Steen K & Berglund A

Ekonomiska konsekvenser av mäns våld mot kvinnor - En kunskapsöversikt samt kostnadsberäkningar utifrån

tre typfall. I: Att fråga om våldsutsatthet som en del i anamnesen.

Uppsala: NCK-rapport 2010:4

Glenngård AH, Svensson J & Persson U

Missbrukets ekonomiska börda i Sverige, Kapitel 19

Missbruket, Kunskapen, Vården. Missbruksutredningens forskningsbilaga. Delbetänkande av

Missbruksutredningen.

Stockholm SOU 2011:6

Eriksson M, Karlsson J, Steen Carlsson K, Dahlin LB, Rosberg HE

Economic consequences of accidents to hands and forearms by log splitters and circular saws: Cost of illness

study.

Journal of Plastic Surgery and Hand Surgery 2011; 45(1): 28-34

ihe publications 2011-2015 · terapi kan ge ökad effektivitet läkartidningen, 2014 jun 11-17; 111...

Documents